|
|
 |
|
Viewing report
|
|
 |
 |
Multiplexed Diagnostics 2009 Market Report
Select Biosciences Ltd, March 2009, Pages: 492
Multiplexed diagnostics are the long-awaited ascendance of ’omics into healthcare. The promise of multiple measurements to characterize complexity is finally being realized. Multiplexed diagnostics, which are combinations of independent measurements or discrete multivariate signatures, are enlightening physicians about improved diagnoses and predictions of responses to treatments and elevating the consistency and efficiency of the entire healthcare system, while all-powerful regulators watch from above with minimal interference. The ascendance of individual tests, however, is fraught with unstable reimbursement and an ever-intensifying storm of competition. On balance, though, the market is uplifting, according to a new report, Multiplexed Diagnostics 2009. The market is estimated to be more than $1.9 billion in 2008 and is projected to grow to more than $5.8 billion by 2014.
Successful ascendance of individual tests requires a detailed understanding of the market. Multiplexed Diagnostics 2009 explains the unmet needs, trends, regulations, reimbursement, competition, technologies and business strategies. The 492-page report includes a survey of almost 250 respondents, interviews with 9 experts, a detailed database of more than 265 commercial multiplexed diagnostics and a two-tiered quantitative worldwide market model.
Customers who bought this item also bought
Multiplexed Diagnostics 2008 Market Report
Infectious Diseases Drugs Markets
European Point of Care (POC) Infectious Disease Market
Infectious Disease Testing Market: US, Europe, Japan--Emerging Opportunities and Business Strategies
U.S. Infectious Disease Diagnostics Markets
U.S. Molecular Diagnostics Markets for Emerging Infectious Disease Tests
Infectious Disease Diagnostics Markets in sub-Saharan Africa
The Chicago Infectious Disease Board Review
U.S. Infectious Diseases: Sexually Transmitted Disease Diagnostics Markets
Blood Typing, Grouping and Infectious Disease Screening Tests:Analysis of Current and Emerging Assays and Companies Developing New Technologies and Products
European Autoimmune Disease Diagnostics Market
Blood Banking: a Worldwide Market Overview - Facilities, Test Volumes, and Sales Forecasts for Typing, Grouping and Infectious Disease Screening Tests by Country
|
 |
|
|